收藏本站
热门搜索: A3500  E1910  A1360  25200056  dmem  

淋巴细胞分离液(LSM,诊断级别)Lymphosep - Lymphocyte Separation Medium

 
包装: 500 mL
运保温度: 15-30°C
到货周期: 登录后查看
标准价: ¥客户可见
会员价: ¥客户可见
积分: 客户可见
 
登录之后可加入购物车购买,请您 
对比 收藏

运费与支付说明:

1.含干冰类产品有运费;

2. 必须现金付款或有信用额度的会员才可以直接发货,否则需要等待现金付款信息。

描述:

Lympho Sep Lymphocyte Separation Medium

LymphoSep™ is a sterile, isosmotic, low viscosity Ficoll-Sodium Metrizoate medium which offers a quick and reliable method for the simple isolation of lymphocytes from whole blood. It is certified for In Vitro Diagnostic (IVD) use and facilitates the isolation of lymphocytes from defribinated EDTA or heparin treated human blood.


For in vitro isolation of lymphocytes from defibrinated , EDTA or heparinized treated human blood.

Hide details for SUMMARY & EXPLANATION
SUMMARY & EXPLANATION 

The use of LymphoSepTM offers a quick, simple and reliable method for isolating lymphocytes from whole blood.

Boyum developed some of the early techniques of separation utilizing erythrocyte aggregating agents1. He subsequently noted that the low viscosity of Ficoll made it possible to isolate lymphocytes utilizing a procedure involving a short low speed centrifugation2. Other investigators developed modifications of the procedure by mixing Ficoll with sodium metrizoate3,4 or sodium diatrizoate5 for the preparation of viable lymphocytes in high yields.

LymphoSepTM is a mixture of Sodium Metrizoate and Ficoll at a density of 1.077 + 0.001 which aggregates the erythrocytes, thereby increasing their sedimentation rate allowing separation from lymphocytes.

Hide details for PRINCIPLE OF THE PROCEDURE
PRINCIPLE OF THE PROCEDURE

 

Fresh blood (not more than 2 hours after collection) is defribinated or treated with anti-coagulant such as EDTA or Heparin. Defibrination has the advantage of removing most platelets from the blood sample.

The blood is then diluted 1:1 with a balanced salt solution. This controls the degree of aggregation of red blood cells so that they sediment easily with a minimum of lymphocyte entrapment. Various solutions can be used for this purpose, including RPMI 1640 or phosphate buffered saline. The diluted blood is layered on the LyphoSepTM in a siliconized glass centrifuge tube and the preparation centrifuged to achieve the separation of lymphocyte.

Hide details for WARNINGS AND PRECAUTIONS
WARNINGS AND PRECAUTIONS
 

  • For in Vitro Diagnostic Use.
  • Dilution or adulteration of this reagent may result in inadequate lymphocyte separation.
  • Do not use reagent beyond expiration date.
  • Patient specimens and all materials coming into contact with them should be handled as if capable of transmitting infection and disposed of with proper precautions.
  • Never pipette by mouth and avoid contact with skin and mucus membranes.
  • Do not expose reagent to strong light during storage.
  • Avoid microbial contamination of reagents or incorrect results may occur.
  • Centrifugation times or temperatures other than those specified may give erroneous results.
  • If the fractions being isolated are to be used in cell culture, sterile equipment and aseptic techniques must be utilized throughout the procedure.


Hide details for STABILITY AND STORAGE
STABILITY AND STORAGE 

LymphoSepTM is stable for 2 years provided the solution is kept sterile and protected from light. Direct sunlight exposure over long periods of time leads to a breakdown in Sodium Metrizoate with release of iodine. Day to day working with this solution will not cause such a breakdown. LymphoSepTM should be stored at room temperature (15o to 20oC).

Hide details for SPECIMEN COLLECTION AND HANDLING
SPECIMEN COLLECTION AND HANDLING

Only fresh blood should be used to insure good separation and high viability of isolated cells. At least 3 ml of blood is collected fresh as a minimum working volume for this procedure. The blood should be kept at room temperature 15-20oC prior to and during centrifugation, and should be collected aseptically in the presence of EDTA or heparin. Blood should be processed within two hours of collection for maximum separation and functionability. However, acceptable separation can be obtained for up to six hours.

It has been shown that in the presence of ACD this product does not meet our specifications. The effect of other anticoagulants with the exception of EDTA and heparin has not been demonstrated.

Hide details for MATERIAL REQUIRED BUT NOT PROVIDED
MATERIAL REQUIRED BUT NOT PROVIDED

1. Glass or plastic test tubes-siliconized

2. Balanced salts solution or RPMI 1640 tissue culture medium.

3. Tris Buffered saline :
 

    a. Glucose 1.00 g/l 
    CaCl2, 2H2O 0.0074 g/l 
    MgCl2 0.1992 g/l
    KCl 0.4026 g/l 
    Tris 17.565 g/l 

    Dissolve in 950 ml distilled, deionized H2O and adjust pH 7.6 with HCl. Make up volume to 1 liter.

    b. NaCl, 8.19 g/l. Dissolve in 950 ml distilled, deionized H2O. Make up volume to 1 liter. Mix 1 volume of (a) with 9 volumes (b) for final Tris buffered saline working solution.


4. Pasteur pipettes

5. Centrifuge tubes.

6. Centrifuge capable of producing at least 300 xG and maintaining 15-30oC temperature.

Hide details for TEST PROTOCOL
TEST PROTOCOL

The efficiency of separation, i.e. the yield of lymphocytes and the degree of contamination by erythrocytes, is chiefly dependent on the height of the blood layer in the centrifuge tube compared with the area of the interface between the blood and the separation medium. The following method will produce the most efficient separation.

1. Dispense 4 ml of LymphoSepTM into a 10 ml siliconized glass centrifuged tube.

2. Carefully layer 2 ml of blood sample diluted 1:1 with PBS or balanced salt solution.

3. Centrifuge for 30 minutes at 400xG. The temperature should be between 18 and 20oC.

Larger volumes of blood can be separated with the same efficiency, using identical centrifuge methods, by employing tubes of greater diameter, while maintaining the same depths of blood and separation medium layers. It is possible to obtain greater numbers of lymphocytes by layering up to double the amount of blood recommended above. This will result in some erythrocyte contamination which may not be prohibitive, depending on the use intended for the separated cells.

We recommend that the investigator determine experimentally the method most suited to the facilities available and the nature of the investigation.

Hide details for WASHING OF LYMPHOCYTES
WASHING OF LYMPHOCYTES

After centrifugation, the lymphocytes will have formed a gray colored layer at the interface of the blood plasma and the separation medium.
 

  1. Using of Pasteur pipette, aspirate the supernatant blood plasma down to the upper surface of the lymphocyte layer, being careful not to disturb the lymphocytes. The plasma can be discarded.
  2. Aspirate the layer of lymphocytes with a clean Pasteur pipette. Try to avoid aspirating any separation medium as this can interfere with subsequent washing and cause contamination with granulocytes.
  3. Transfer the lymphocytes to a centrifuge tube containing at least three times the volume of balanced salt solution or PBS. Suspend evenly.
  4. Centrifuge the lymphocyte suspension at 100xG for 10-15 minutes. Aspirate the supernatant and discard.
  5. Resuspend the cell pellet in fresh balanced salt solution or PBS by gently drawing the cells in and out of a Pasteur pipette. Repeat step 3 and 4.


Hide details for PERFORMANCE CHARACTERISTICS & EXPECTED RESULTS
PERFORMANCE CHARACTERISTICS & EXPECTED RESULTS

MNC Fraction Composition : X%S.D.
Lymphocytes 55.0 + 16.1%
Monocytes 43.0 + 16.1%
Polycytes 1.6 + 1.9%
Eosinophils 0.0 + 0.0%
Basophils 0.2 + 0.6%

MNC Viability :

98.8 + 1.7% 

A minimum of 30% + 10% in recovered lymphocyte can be expected. The values were obtained using whole female blood with heparin from Interstate Blood Bank Inc. Blood from the 21 donors was washed at least once with PBS to remove traces of the separation medium. Viability of each fraction, after separation, was tested using the Trypan blue dye exclusion method. Cell purity was assayed by differential cell counts on all fractions using rapid Wright's stain.

Hide details for LIMITATIONS OF PROCEDURE
LIMITATIONS OF PROCEDURE

Use of ACD anticoagulant is not recommended for this procedure.

The effects of other anticoagulants , except EDTA or heparin has not been demonstrated.

Hide details for REFERENCES
REFERENCES
 

  1. Boyum, A., Scan J Clin. Invest, v. 21 Suppl, 97, 1968.
  2. Day, R.P., Clinical Allergy, v. 2, 205-212, 1972
  3. Goldrosen, M.H., Gannon, P.J., Lutz, M., and Holyoke, E.D., Immunol. Methods, v. 14, 15-17, 1977
  4. Loos, J.A. and Roos, D., Exp. Cell Res., v. 86, 333-341, 1974
  5. Mendelsohn, J., Skinner, A., and Kornfield, S., J. Clin. Invest., v. 50, 818-826, 1971


Hide details for TROUBLE SHOOTING
TROUBLE SHOOTING



Trouble Shooting Guide
Problem Possible Cause Solution
RBC Contamination Saline diluted blood of low viscosity plasma. Increase centrifuge speed
Temperature not correct Adjust to proper temperature
No defined or distinct mononuclear layer Volume of blood to low. Add more blood or dilute blood (1:2) with saline
Centrifuge speed to low Increase time or speed of centrifugation.


相关图片

说明书

参考文献

本产品可用于的实验

购此产品的人还购买了
最近浏览产品

京ICP备15036693号-2    京公网安备11010802025653    版权所有:北京逸优科技有限公司       0.04

 纠 错